A Study of Valganciclovir in the Treatment of Cytomegalovirus (CMV) Retinitis in Patients With AIDS
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if valganciclovir is a safe treatment for CMV retinitis
in patients who have been treated for this condition in the past. This study also examines
the effectiveness of valganciclovir in preventing the recurrence of CMV retinitis.